Patent Owners ‘Fleeing’ RPX Acquisition Model

Patent owners, including several currently relying on litigation, are “fleeing” RPX in favor of ICAP’s new Covenant Not to Sue (“CNS”) program, according to a source working closely with the brokerage firm.  RPX may not be dead quite yet, but ICAP has their shovels out, ready to lend a hand digging RPX’s grave.  Patent owners predictably prefer ICAP to RPX for a number of reasons, but a good turn-out of corporate representatives ready to acquire rights will confirm that both buyers and sellers want an ala carte marketplace for IP dealmaking.